v3.25.1
DEBT (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
May 31, 2023
Feb. 28, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Mar. 21, 2024
Mar. 20, 2024
Jul. 02, 2023
Jan. 31, 2023
Debt Instrument [Line Items]                        
Notes payable         $ 173,650 $ 79,250            
Bear interest rate         8.00%              
Loans payable   $ 100,000                    
Interest paid $ 22,718 50     $ 6,500              
Borrowed outstanding           100,000            
Accrues interest payable   250     125              
Interest paid in stock   $ 200                    
Stock share paid per value   $ 0.20                    
Additional interest paid in cash   $ 7,500                    
Related party loan amount $ 153,989                      
Related party issued loan amount, net         145,712 130,074            
Notes payable discount         8,277 23,915            
Loan percentage per year 12.50%                      
Principal amount paid         40,000              
Line of credit         48,061 0            
Convertible notes payable, net discount         318,779 0            
Long-term convertible notes payable         1,127,621 2,641,000            
Convertible notes payable         $ 3,673,037 $ 1,178,787            
Conversion shares         28,170,065 10,830,890            
Common shares unissued         1,954,250 8,110,690            
Convertible notes payable remain outstanding           $ 2,810,250            
Share price         $ 0.3600              
Warrants price per share                     $ 0.001  
Convertible long term notes payable         $ 2,262,263              
Short-term convertible notes payable         815,863 32,154            
Convertible net of discount         24,400 $ 137,096            
Convertible Notes Payable [Member]                        
Debt Instrument [Line Items]                        
Notes payable $ 90,000       $ 750,000       $ 60,000     $ 69,250
Bear interest rate         10.00% 8.00% 8.00%          
Convertible note payable with a related party               $ 25,000        
Convertible per share               $ 0.001        
Number of value sale           $ 3,000            
Converted shares loan           3,000,000            
Convertible notes payable, net discount         $ 2,582,650 $ 3,971,500 $ 1,461,000          
Notes and Loans Payable           1,075,000 $ 386,000          
Long-term convertible notes payable           $ 75,000            
Debt instrument second notes payable maturity date           Sep. 25, 2024            
Debt instrument third notes payable maturity date           Dec. 29, 2024            
Discount rate         35.00%         35.00%    
Share price         $ 0.35              
Issuance of common shares         150,000              
Notes payables         $ 300,000              
Interest rate         9.00%              
Warrants shares         300,000              
Warrants price per share         $ 0.80              
Convertible Notes Payable [Member] | Minimum [Member]                        
Debt Instrument [Line Items]                        
Shares and convertible common stock range             $ 0.10          
Convertible Notes Payable [Member] | Maximum [Member]                        
Debt Instrument [Line Items]                        
Shares and convertible common stock range             $ 0.25          
Convertible Notes Payable 1 [Member]                        
Debt Instrument [Line Items]                        
Notes payable         $ 173,650              
Notes payables         $ 300,000              
Interest rate         10.00%              
Convertible Note Payable [Member]                        
Debt Instrument [Line Items]                        
Notes payable         $ 150,000              
Notes Payable [Member]                        
Debt Instrument [Line Items]                        
Purchase price       $ 450,000                
Debt discount       $ 389,046                
Repayment debt         106,500 $ 106,500            
Debt balance         $ 343,500 $ 343,500            
Notes payable             $ 100,000          
Interest expense             10,000          
Repayment of notes payable             50,000          
Cash converted             60,000          
Note payable related party             $ 15,000          
Bear interest rate             7.00%          
Notes Payable [Member] | KAM Biotechnology [Member]                        
Debt Instrument [Line Items]                        
Total acquisition price     $ 800,000                  
Acquisition price after discount     $ 758,501